Friday, September 30, 2016

Xenical


Xenical is a brand name of orlistat, approved by the FDA in the following formulation(s):


XENICAL (orlistat - capsule; oral)



  • Manufacturer: HOFFMANN LA ROCHE

    Approval date: April 23, 1999

    Strength(s): 120MG [RLD]

Has a generic version of Xenical been approved?


No. There is currently no therapeutically equivalent version of Xenical available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xenical. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Tetrahydrolipstatin containing compositions
    Patent 6,004,996
    Issued: December 21, 1999
    Inventor(s): Shah; Navnit Hargovindas & Zeller; Max
    Assignee(s): Hoffman-La Roche Inc.
    Product containing tetrahydrolipstatin as the active ingredient and pharmaceutically acceptable excipients, characterized in that it is in the form of particles with a diameter of 0.25 to 2 mm; and pharmaceutical preparation s or compositions for oral administration containing the product.
    Patent expiration dates:

    • January 6, 2018


    • July 6, 2018
      ✓ 
      Pediatric exclusivity



See also...

  • Xenical Consumer Information (Drugs.com)
  • Xenical Consumer Information (Wolters Kluwer)
  • Xenical Consumer Information (Cerner Multum)
  • Xenical Advanced Consumer Information (Micromedex)
  • Xenical AHFS DI Monographs (ASHP)
  • Orlistat Consumer Information (Drugs.com)
  • Orlistat Consumer Information (Wolters Kluwer)
  • Orlistat Consumer Information (Cerner Multum)
  • Orlistat Advanced Consumer Information (Micromedex)
  • Orlistat AHFS DI Monographs (ASHP)

No comments:

Post a Comment